|
1
|
Jampol LM, Glassman AR and Sun J:
Evaluation and care of patients with diabetic retinopathy. N Engl J
Med. 382:1629–1637. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kase S, Saito W, Ohno S and Ishida S:
Proliferative diabetic retinopathy with lymphocyte-rich epiretinal
membrane associated with poor visual prognosis. Invest Ophthalmol
Vis Sci. 50:5909–5912. 2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chaudhuri J, Bains Y, Guha S, Kahn A, Hall
D, Bose N, Gugliucci A and Kapahi P: The role of advanced glycation
end products in aging and metabolic diseases: Bridging association
and causality. Cell Metab. 28:337–352. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zong H, Ward M, Madden A, Yong PH, Limb
GA, Curtis TM and Stitt AW: Hyperglycaemia-induced pro-inflammatory
responses by retinal Müller glia are regulated by the receptor for
advanced glycation end-products (RAGE). Diabetologia. 53:2656–2666.
2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chen L, Cui Y, Li B, Weng J, Wang W, Zhang
S, Huang X, Guo X and Huang Q: Advanced glycation end products
induce immature angiogenesis in in vivo and ex vivo mouse models.
Am J Physiol Heart Circ Physiol. 318:H519–H533. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Makita Z, Radoff S, Rayfield EJ, Yang Z,
Skolnik E, Delaney V, Friedman EA, Cerami A and Vlassara H:
Advanced glycosylation end products in patients with diabetic
nephropathy. N Engl J Med. 325:836–842. 1991.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Monnier VM, Sell DR and Genuth S:
Glycation products as markers and predictors of the progression of
diabetic complications. Ann N Y Acad Sci. 1043:567–581.
2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Stitt AW: AGEs and diabetic retinopathy.
Invest Ophthalmol Vis Sci. 51:4867–4874. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xu J, Chen LJ, Yu J, Wang HJ, Zhang F, Liu
Q and Wu J: Involvement of advanced glycation end products in the
pathogenesis of diabetic retinopathy. Cell Physiol Biochem.
48:705–717. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Moore TC, Moore JE, Kaji Y, Frizzell N,
Usui T, Poulaki V, Campbell IL, Stitt AW, Gardiner TA, Archer DB
and Adamis AP: The role of advanced glycation end products in
retinal microvascular leukostasis. Invest Ophthalmol Vis Sci.
44:4457–4464. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ghosh JG, Shenoy AK Jr and Clark JI:
Interactions between important regulatory proteins and human alphaB
crystallin. Biochemistry. 46:6308–6317. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mymrikov EV, Seit-Nebi AS and Gusev NB:
Large potentials of small heat shock proteins. Physiol Rev.
91:1123–1159. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rothbard JB, Kurnellas MP, Brownell S,
Adams CM, Su L, Axtell RC, Chen R, Fathman CG, Robinson WH and
Steinman L: Therapeutic effects of systemic administration of
chaperone αB-crystallin associated with binding proinflammatory
plasma proteins. J Biol Chem. 287:9708–9721. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ousman SS, Tomooka BH, van Noort JM,
Wawrousek EF, O'Connor KC, Hafler DA, Sobel RA, Robinson WH and
Steinman L: Protective and therapeutic role for alphaB-crystallin
in autoimmune demyelination. Nature. 448:474–479. 2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kannan R, Sreekumar PG and Hinton DR:
Alpha crystallins in the retinal pigment epithelium and
implications for the pathogenesis and treatment of age-related
macular degeneration. Biochim Biophys Acta. 1860:258–268.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kase S, He S, Sonoda S, Kitamura M, Spee
C, Wawrousek E, Ryan SJ, Kannan R and Hinton DR: AlphaB-crystallin
regulation of angiogenesis by modulation of VEGF. Blood.
115:3398–3406. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dong Z, Kase S, Ando R, Fukuhara J, Saito
W, Kanda A, Murata M, Noda K and Ishida S: Alphab-crystallin
expression in epiretinal membrane of human proliferative diabetic
retinopathy. Retina. 32:1190–1196. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kase S, Ishida S and Rao NA: Increased
expression of αA-crystallin in human diabetic eye. Int J Mol Med.
28:505–511. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kase S, Ishida S and Rao NA:
Immunolocalization of advanced glycation end products in human
diabetic eyes: An immunohistochemical study. J Diabetes Mellit.
1:57–62. 2011.
|
|
20
|
Endo M, Yanagisawa K, Tsuchida K, Okamoto
T, Matsushita T, Higuchi M, Matsuda A, Takeuchi M, Makita Z and
Koike T: Increased levels of vascular endothelial growth factor and
advanced glycation end products in aqueous humor of patients with
diabetic retinopathy. Horm Metab Res. 33:317–322. 2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Stitt AW, Moore JE, Sharkey JA, Murphy G,
Simpson DA, Bucala R, Vlassara H and Archer DB: Advanced glycation
end products in vitreous: Structural and functional implications
for diabetic vitreopathy. Invest Ophthalmol Vis Sci. 39:2517–2523.
1998.PubMed/NCBI
|
|
22
|
Boehm BO, Schilling S, Rosinger S, Lang
GE, Lang GK, Kientsch-Engel R and Stahl P: Elevated serum levels of
N(epsilon)-carboxymethyl-lysine, an advanced glycation end product,
are associated with proliferative diabetic retinopathy and macular
oedema. Diabetologia. 47:1376–1379. 2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hase K, Kanda A, Noda K and Ishida S:
Increased plasma galectin-1 correlates with advanced glycation end
products and interleukin-1β in patients with proliferative diabetic
retinopathy. Int J Ophthalmol. 12:692–694. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen W, Lu Q, Lu L and Guan H: Increased
levels of alphaB-crystallin in vitreous fluid of patients with
proliferative diabetic retinopathy and correlation with vascular
endothelial growth factor. Clin Exp Ophthalmol. 45:379–384.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Baba T, Oshitari T and Yamamoto S: Level
of vitreous alpha-B crystallin in eyes with rhegmatogenous retinal
detachment. Graefes Arch Clin Exp Ophthalmol. 253:1251–1254.
2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Klein R, Klein BE, Magli YL, Brothers RJ,
Meuer SM, Moss SE and Davis MD: An alternative method of grading
diabetic retinopathy. Ophthalmology. 93:1183–1187. 1986.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang W, Xu Q, Wu J, Zhou X, Weng J, Xu J,
Wang W, Huang Q and Guo X: Role of src in vascular
hyperpermeability induced by advanced glycation end products. Sci
Rep. 5(14090)2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Choudhuri S, Dutta D, Sen A, Chowdhury IH,
Mitra B, Mondal LK, Saha A, Bhadhuri G and Bhattacharya B: Role of
N-ε-carboxy methyl lysine, advanced glycation end products and
reactive oxygen species for the development of nonproliferative and
proliferative retinopathy in type 2 diabetes mellitus. Mol Vis.
19:100–113. 2013.PubMed/NCBI
|
|
29
|
Loho T, Venna V, Setiabudy RD, Sukartini
N, Immanuel S, Kumalawati J, Victor AA and Waspadji S: Correlation
between vitreous advanced glycation end products, and D-dimer with
blood HbA1c levels in proliferative diabetic retinopathy. Acta Med
Indones. 50:132–137. 2018.PubMed/NCBI
|
|
30
|
Sanchis P, Rivera R, Fortuny R, Rio C,
Mas-Gelabert M, Gonzalez-Freire M, Grases F and Masmiquel L: Role
of advanced glycation end products on aortic calcification in
patients with type 2 diabetes mellitus. J Clin Med.
9(1751)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Dong Y, Dong Z, Kase S, Ando R, Fukuhara
J, Kinoshita S, Inafuku S, Tagawa Y, Ishizuka ET, Saito W, et al:
Phosphorylation of alphaB-crystallin in epiretinal membrane of
human proliferative diabetic retinopathy. Int J Ophthalmol.
9:1100–1105. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
D'Agostino M, Scerra G, Cannata Serio M,
Caporaso MG, Bonatti S and Renna M: Unconventional secretion of
α-Crystallin B requires the Autophagic pathway and is controlled by
phosphorylation of its serine 59 residue. Sci Rep.
9(16892)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kore RA and Abraham EC: Inflammatory
cytokines, interleukin-1 beta and tumor necrosis factor-alpha,
upregulated in glioblastoma multiforme, raise the levels of CRYAB
in exosomes secreted by U373 glioma cells. Biochem Biophys Res
Commun. 453:326–331. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ransom RF, Vega-Warner V, Smoyer WE and
Klein J: Differential proteomic analysis of proteins induced by
glucocorticoids in cultured murine podocytes. Kidney Int.
67:1275–1285. 2005.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Cano-Valderrama O, Morales X, Ferrigni CJ,
Martin-Antona E, Turrado V, Garcia A, Cuñarro-López Y,
Zarain-Obrador L, Duran-Poveda M, Balibrea JM and Torres AJ:
Reduction in emergency surgery activity during COVID-19 pandemic in
three Spanish hospitals. Br J Surg. 107(e239)2020.PubMed/NCBI View Article : Google Scholar
|
